| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |